Pharmacogenetics: From Bench to Byte- An Update of Guidelines by Swen J J, Nijenhuis M, de Boer A, Grandia L, Maitland-van der Zee A H, Mulder H, Rongen G A P J M, van Schaik R H N, Schalekamp T, Touw D J, van der Weide J, Wilffert B, Deneer V H M, Guchelaar H-J in Clinical pharmacology and therapeutics (2011).

[PMID: 21412232] PubMed

Abstract

Discussed In Paper

Loading...

Rx Annotations

Annotation of DPWG Guideline for abacavir and HLA-B
Annotation of DPWG Guideline for acenocoumarol and CYP2C9
Annotation of DPWG Guideline for acenocoumarol and VKORC1
Annotation of DPWG Guideline for amitriptyline and CYP2D6
Annotation of DPWG Guideline for aripiprazole and CYP2D6
Annotation of DPWG Guideline for atomoxetine and CYP2D6
Annotation of DPWG Guideline for azathioprine and TPMT
Annotation of DPWG Guideline for capecitabine and DPYD
Annotation of DPWG Guideline for carvedilol and CYP2D6
Annotation of DPWG Guideline for citalopram and CYP2C19
Annotation of DPWG Guideline for clomipramine and CYP2D6
Annotation of DPWG Guideline for clopidogrel and CYP2C19
Annotation of DPWG Guideline for clozapine and CYP2D6
Annotation of DPWG Guideline for codeine and CYP2D6
Annotation of DPWG Guideline for doxepin and CYP2D6
Annotation of DPWG Guideline for duloxetine and CYP2D6
Annotation of DPWG Guideline for escitalopram and CYP2C19
Annotation of DPWG Guideline for esomeprazole and CYP2C19
Annotation of DPWG Guideline for flecainide and CYP2D6
Annotation of DPWG Guideline for fluorouracil and DPYD
Annotation of DPWG Guideline for flupenthixol and CYP2D6
Annotation of DPWG Guideline for glibenclamide and CYP2C9
Annotation of DPWG Guideline for gliclazide and CYP2C9
Annotation of DPWG Guideline for glimepiride and CYP2C9
Annotation of DPWG Guideline for haloperidol and CYP2D6
Annotation of DPWG Guideline for hormonal contraceptives for systemic use and F5
Annotation of DPWG Guideline for imipramine and CYP2C19
Annotation of DPWG Guideline for imipramine and CYP2D6
Annotation of DPWG Guideline for irinotecan and UGT1A1
Annotation of DPWG Guideline for lansoprazole and CYP2C19
Annotation of DPWG Guideline for mercaptopurine and TPMT
Annotation of DPWG Guideline for metoprolol and CYP2D6
Annotation of DPWG Guideline for mirtazapine and CYP2D6
Annotation of DPWG Guideline for moclobemide and CYP2C19
Annotation of DPWG Guideline for nortriptyline and CYP2D6
Annotation of DPWG Guideline for olanzapine and CYP2D6
Annotation of DPWG Guideline for omeprazole and CYP2C19
Annotation of DPWG Guideline for oxycodone and CYP2D6
Annotation of DPWG Guideline for pantoprazole and CYP2C19
Annotation of DPWG Guideline for paroxetine and CYP2D6
Annotation of DPWG Guideline for phenprocoumon and CYP2C9
Annotation of DPWG Guideline for phenprocoumon and VKORC1
Annotation of DPWG Guideline for phenytoin and CYP2C9
Annotation of DPWG Guideline for propafenone and CYP2D6
Annotation of DPWG Guideline for rabeprazole and CYP2C19
Annotation of DPWG Guideline for ribavirin and HLA-B
Annotation of DPWG Guideline for risperidone and CYP2D6
Annotation of DPWG Guideline for sertraline and CYP2C19
Annotation of DPWG Guideline for tacrolimus and CYP3A5
Annotation of DPWG Guideline for tamoxifen and CYP2D6
Annotation of DPWG Guideline for tegafur and DPYD
Annotation of DPWG Guideline for thioguanine and TPMT
Annotation of DPWG Guideline for tolbutamide and CYP2C9
Annotation of DPWG Guideline for tramadol and CYP2D6
Annotation of DPWG Guideline for venlafaxine and CYP2D6
Annotation of DPWG Guideline for voriconazole and CYP2C19
Annotation of DPWG Guideline for zuclopenthixol and CYP2D6